Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557

Watchlist Manager
Jiangsu Kanion Pharmaceutical Co Ltd Logo
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Watchlist
Price: 14.31 CNY 1.71%
Market Cap: 8.2B CNY
Have any thoughts about
Jiangsu Kanion Pharmaceutical Co Ltd?
Write Note
Jiangsu Kanion Pharmaceutical Co Ltd
/
Balance Sheet
/
Other Long-Term Assets

Jiangsu Kanion Pharmaceutical Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiangsu Kanion Pharmaceutical Co Ltd
Other Long-Term Assets Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Other Long-Term Assets
¥60m
CAGR 3-Years
15%
CAGR 5-Years
-13%
CAGR 10-Years
-2%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Long-Term Assets
¥215.7m
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
8%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Long-Term Assets
¥702.3m
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
36%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Long-Term Assets
¥928.6m
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Long-Term Assets
¥84.9m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jiangsu Kanion Pharmaceutical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
60m CNY

Based on the financial report for Jun 30, 2024, Jiangsu Kanion Pharmaceutical Co Ltd's Other Long-Term Assets amounts to 60m CNY.

What is Jiangsu Kanion Pharmaceutical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-2%

Over the last year, the Other Long-Term Assets growth was 37%. The average annual Other Long-Term Assets growth rates for Jiangsu Kanion Pharmaceutical Co Ltd have been 15% over the past three years , -13% over the past five years , and -2% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 193,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.